Pharmaceuticals

We are developing novel strategies for identifying new molecular entities with high biological activity. Our unique approach to drug discovery allows us to identify promising lead compounds at a rate far greater than otherwise attainable via conventional methods.

Software

Paragen has developed a new software application for identifying and facilitating the laboratory synthesis of high-potential new molecular entities.
 
Latest Company News
  (dec12 | 2006) Patent application entitled "Intellectual property related method and computer program" filed.

  (dec17 | 2007) Patent application entitled "UV-absorbing phenol ester compounds" filed.

  (jan 16 | 2008) Patent application entitled "Benzyl phenyl ether compounds" filed.

  (jun 04 | 2008) Patent application entitled "Phenyl amide compounds" filed.

  (jun 12 | 2008) Patent application entitled "Intellectual property related method and computer program" published as U.S. Patent Application No. 2008/0140695 A1.

Company Resources

Intellectual Property
Selection of patents pending from Paragen's portfolio.


Publications
Paragen makes research available to other scientists and to the public.

Research
New molecular entitles and pharmaceutical drug discovery.


Investor Relations
Information for current and prospective investors.

 

 
Paragen, Inc.© 2008